Nisa Investment Advisors LLC increased its holdings in Humana Inc. (NYSE:HUM – Free Report) by 27.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 31,429 shares of the insurance provider’s stock after acquiring an additional 6,784 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Humana were worth $11,992,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. acquired a new position in Humana in the 2nd quarter valued at about $4,138,160,000. Pzena Investment Management LLC boosted its position in shares of Humana by 34.3% during the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after purchasing an additional 1,398,774 shares in the last quarter. Assenagon Asset Management S.A. grew its position in Humana by 20,126.8% during the third quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider’s stock worth $479,053,000 after buying an additional 1,249,272 shares during the period. Legal & General Group Plc purchased a new position in Humana in the 2nd quarter valued at approximately $329,760,000. Finally, Barrow Hanley Mewhinney & Strauss LLC purchased a new position in Humana in the 2nd quarter valued at approximately $314,922,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently issued reports on HUM shares. Citigroup initiated coverage on Humana in a report on Friday, October 9th. They set a “buy” rating for the company. Wolfe Research reissued an “outperform” rating and issued a $450.00 target price on shares of Humana in a report on Monday, August 24th. HSBC cut Humana to a “hold” rating in a research report on Thursday, July 30th. Morgan Stanley raised Humana from an “underweight” rating to an “overweight” rating in a research note on Friday, October 9th. Finally, Evercore upgraded shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price objective on the stock in a research report on Wednesday, July 29th. Twenty-one analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Humana has a consensus rating of “Moderate Buy” and a consensus price target of $453.30.
View Our Latest Research Report on HUM
Humana Stock Performance
Shares of NYSE HUM opened at $420.97 on Friday. The company has a 50-day simple moving average of $397.28 and a 200-day simple moving average of $350.57. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The company has a market cap of $50.55 billion, a PE ratio of 24.73, a price-to-earnings-growth ratio of 2.62 and a beta of 0.74. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $456.50.
Humana (NYSE:HUM – Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The business had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s quarterly revenue was up 26.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.27 earnings per share. On average, equities analysts anticipate that Humana Inc. will post 9.03 earnings per share for the current year.
Humana Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be issued a $0.8850 dividend. The ex-dividend date is Friday, October 30th. This represents a $3.54 annualized dividend and a yield of 0.8%. Humana’s payout ratio is 33.49%.
Humana Company Profile
Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.
Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.
Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.
Featured Articles
- Five stocks we like better than Humana
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
